Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
5,060.00
+1,165.00 (29.91%)
At close: Dec 5, 2025
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 140.05 billion as of December 5, 2025. Its market cap has increased by 35.48% in one year.
Market Cap
140.05B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
83.86
Stock Price
5,060.00
Market Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 140.05B, an increase of 386.71%. That is a compound annual growth rate of 5.36%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.30T |
| ALTEOGEN | 27.86T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.53T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 6,907.33B |
| Peptron | 6,668.76B |